Literature DB >> 628386

Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells.

H J Alter, E Tabor, H T Meryman, J H Hoofnagle, R A Kahn, P V Holland, R J Gerety, L F Barker.   

Abstract

Chimpanzees were used to determine the ability of prior freezing of red blood cells to prevent the transmission of Type B post-transfusion hepatitis. Four units of human whole blood were each inoculated with 10(6) infectious doses of hepatitis B virus. Although all units became HBsAg negative after freezing and deglycerolization, hepatitis B virus infection developed in all four chimpanzees when these units were transfused. Two of these chimpanzees had only serologic evidence of infection, including the development of HBsAg and antibody to both the hepatitis B surface and core antigens; in these animals, the incubation periods were prolonged (24 to 25 weeks). In contrast, the other two animals also had elevated serum glutamic pyruvic transaminase (peaks of 190 and 461 IU per liter) and had a more rapid onset. There was no hepatitis B virus infection in two nontransfused controls. Our results do not support the use of frozen red blood cells for the prevention of post-transfusion hepatitis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 628386     DOI: 10.1056/NEJM197803232981201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  4 in total

1.  The appropriate role of frozen-stored red blood cells in transfusion practice.

Authors:  H Chaplin
Journal:  World J Surg       Date:  1987-02       Impact factor: 3.352

2.  Prevalence of hepatitis B in 27 Michigan hemodialysis centers.

Authors:  G H Mayor; M R Hourani; D S Greenbaum; M J Patterson
Journal:  Am J Public Health       Date:  1979-06       Impact factor: 9.308

3.  Cryopreservation of virus-infected cells for use in the fluorescent antibody to membrane antigen test.

Authors:  M Fishaut; N Murphy; R Yanagihara; K McIntosh
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

4.  Development and performance of prototype serologic and molecular tests for hepatitis delta infection.

Authors:  Kelly E Coller; Emily K Butler; Ka-Cheung Luk; Mary A Rodgers; Michael Cassidy; Jeffrey Gersch; Anne L McNamara; Mary C Kuhns; George J Dawson; Lazare Kaptue; Birgit Bremer; Heiner Wedemeyer; Gavin A Cloherty
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.